Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Discovery of Unexpected Phospholipid-Binding Proteins in Antiphospholipid Syndrome Patients

Jacob H Rand, Xiao-Xuan Wu, Lucia R. Wolgast, Douglas M Taatjes, Stephen R Master

Blood (2023) 142 (Supplement 1): 5393.

https://doi.org/10.1182/blood-2023-182506

Published: 2023

Journal Articles

Prediction of Venous Thromboembolism in Patients with Cancer Using Neural Network

Romy De Laat-Kremers, Scott Tagawa, Madeline Young, Christine Garcia, Manish Shah, Pashtoon Murtaza Kasi, Jacob H Rand, Bas De Laat, Maria T DeSancho

Blood (2023) 142 (Supplement 1): 1235.

https://doi.org/10.1182/blood-2023-184990

Published: 2023

Journal Articles

Intermediate Results of the Cornell Blood Coagulation in Cancer Study (COBLOCA-Study)

Romy de Laat-Kremers, Marina Loizou, Scott Tawaga, Jacob H. Rand, Bas de Laat, Maria T DeSancho

Blood (2022) 140 (Supplement 1): 5666–5667.

https://doi.org/10.1182/blood-2022-163240

Published: 2022

Journal Articles

Platelet-Derived Microvesicles Reverse the Lupus Anticoagulant Effect and Are More Potent then Synthetic Phospholipids in Supporting Thrombin Generation in Antiphospholipid Syndrome

Cuicui Bai, PhD, Saartje Bloemen, PhD, Xiao Xuan Wu, MD, Ruchika Goel, MD MPH, Sheshadri Narayanan, Bas De Laat, MD, PhD, Jacob H. Rand, MD PhD, Ljiljana V. Vasovic, MD

Blood (2018) 132 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2018-99-113486

Published: 2018

Journal Articles

Small Angle X-Ray Scattering Reveals the Conformation of Î² 2 glycoprotein I and the Conformational Binding Epitopes of Autoantibodies

Seung J. Kim, PhD, Jacob H. Rand, MD PhD, Philip G. de Groot, PhD, Rolf T. Urbanus, PhD, Dina Schneidman, PhD, Man K. Chan, PhD, Hilde Kelchtermans, PhD, Bas De Laat, MD PhD

Blood (2017) 130 (Supplement 1): 2378.

https://doi.org/10.1182/blood.V130.Suppl_1.2378.2378

Published: 2017

Journal Articles

Antiphospholipid Syndrome (APS) Patient Plasmas Consistently Activate Complement: A Novel Approach to Detecting a Pathogenic Mechanism for APS

Jacob H. Rand, MD, Xiao-Xuan Wu, MD, Lucia R Wolgast, MD, Victor Lei, MSc, Edward M. Conway, MD PhD

Blood (2016) 128 (22): 719.

https://doi.org/10.1182/blood.V128.22.719.719

Published: 2016

Journal Articles

Inverted Erythrocyte Membranes Are a Novel Platform for Expressing Phosphatidylserine and Investigating the Antiphospholipid Syndrome

Saartje Bloemen, PhD, Xiao Xuan Wu, PhD, Bas De Laat, MD PhD, Jacob H. Rand, MD, Ljiljana V. Vasovic, MD

Blood (2015) 126 (23): 2315.

https://doi.org/10.1182/blood.V126.23.2315.2315

Published: 2015

Journal Articles

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Wu Xiao-Xuan, PhD, Silvia Koder, Cihan Ay, MD, Jacob H. Rand, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3555.

https://doi.org/10.1182/blood.V126.23.3555.3555

Published: 2015

Journal Articles

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Jacob H. Rand, MD, Bas de Laat, MDPhD, Silvia Koder, Peter Quehenberger, MD, Cihan Ay, Ingrid Pabinger, MD

Blood (2015) 126 (23): 652.

https://doi.org/10.1182/blood.V126.23.652.652

Published: 2015

Journal Articles

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Ervis Bezati, Xiao Xuan Wu, MD, Jacob H. Rand, MD

Blood (2012) 120 (21): 3423.

https://doi.org/10.1182/blood.V120.21.3423.3423

Published: 2012

Journal Articles

From Phenomenology to Mechanism: Resistance to Annexin A5 Anticoagulant Activity Identifies a Subset of Patients with Antiphospholipid Antibodies and Thrombosis

Lucia R Wolgast, MD, Xiao Xuan Wu, MD, Alan Arslan, MD, Jacob H. Rand, MD

Blood (2012) 120 (21): 631.

https://doi.org/10.1182/blood.V120.21.631.631

Published: 2012

Journal Articles

Home free? Not after 3!

Jacob H. Rand

Blood (2011) 118 (17): 4504–4506.

https://doi.org/10.1182/blood-2011-08-369058

Published: 2011

Journal Articles

A new fish for the β2GPI hook: LPS!

Jacob H. Rand

Blood (2011) 117 (25): 6743–6744.

https://doi.org/10.1182/blood-2011-04-346734

Published: 2011

Journal Articles

How I treat the acquired von Willebrand syndrome

Andreas Tiede, Jacob H. Rand, Ulrich Budde, Arnold Ganser, Augusto B. Federici

Blood (2011) 117 (25): 6777–6785.

https://doi.org/10.1182/blood-2010-11-297580

Published: 2011

Journal Articles

A snappy new concept for APS

Jacob H. Rand

Blood (2010) 116 (8): 1193–1194.

https://doi.org/10.1182/blood-2010-06-288209

Published: 2010

Journal Articles

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Jacob H. Rand, Xiao-Xuan Wu, Anthony S. Quinn, Anthony W. Ashton, Pojen P. Chen, James J. Hathcock, Harry A. M. Andree, Douglas J. Taatjes

Blood (2010) 115 (11): 2292–2299.

https://doi.org/10.1182/blood-2009-04-213520

Published: 2010

Journal Articles

Pathophysiology of Anti-PL Syndrome in Thrombosis.

Jacob H. Rand, MD

Blood (2009) 114 (22): SCI-45.

https://doi.org/10.1182/blood.V114.22.SCI-45.SCI-45

Published: 2009

Journal Articles

Resistance to Annexin A5 Anticoagulant Activity and Specificity for Anti-B2GPI Domain I Antibodies in Obstetric Antiphospholipid Syndrome

Beverley J Hunt, FRCP, FRCPath, MD, Xiao-Xuan Wu, MD, Bas de Laat, Alan A Arslan, MD, Kiran Parmar, MSc, Sarah Stuart-Smith, MD, Jacob H Rand, MD

Blood (2008) 112 (11): 3821.

https://doi.org/10.1182/blood.V112.11.3821.3821

Published: 2008

Journal Articles

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers

Jacob H. Rand, Xiao-Xuan Wu, Anthony S. Quinn, Pojen P. Chen, James J. Hathcock, Douglas J. Taatjes

Blood (2008) 112 (5): 1687–1695.

https://doi.org/10.1182/blood-2008-03-144204

Published: 2008

Journal Articles

Risk Factors for Clinical Manifestations in Patients with Factor V Leiden and Prothrombin Gene Mutations.

Maria Teresa De Sancho, MD, Nickisha Berlus, Jacob H. Rand, MD

Blood (2006) 108 (11): 4090.

https://doi.org/10.1182/blood.V108.11.4090.4090

Published: 2006

NARROW

Discovery of Unexpected Phospholipid-Binding Proteins in Antiphospholipid Syndrome Patients

Prediction of Venous Thromboembolism in Patients with Cancer Using Neural Network

Intermediate Results of the Cornell Blood Coagulation in Cancer Study (COBLOCA-Study)

Platelet-Derived Microvesicles Reverse the Lupus Anticoagulant Effect and Are More Potent then Synthetic Phospholipids in Supporting Thrombin Generation in Antiphospholipid Syndrome

Small Angle X-Ray Scattering Reveals the Conformation of Î² 2 glycoprotein I and the Conformational Binding Epitopes of Autoantibodies

Antiphospholipid Syndrome (APS) Patient Plasmas Consistently Activate Complement: A Novel Approach to Detecting a Pathogenic Mechanism for APS

Inverted Erythrocyte Membranes Are a Novel Platform for Expressing Phosphatidylserine and Investigating the Antiphospholipid Syndrome

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

From Phenomenology to Mechanism: Resistance to Annexin A5 Anticoagulant Activity Identifies a Subset of Patients with Antiphospholipid Antibodies and Thrombosis

Home free? Not after 3!

A new fish for the β2GPI hook: LPS!

How I treat the acquired von Willebrand syndrome

A snappy new concept for APS

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Pathophysiology of Anti-PL Syndrome in Thrombosis.

Resistance to Annexin A5 Anticoagulant Activity and Specificity for Anti-B2GPI Domain I Antibodies in Obstetric Antiphospholipid Syndrome

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers

Risk Factors for Clinical Manifestations in Patients with Factor V Leiden and Prothrombin Gene Mutations.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only